Actively Recruiting
Positive Affect Treatment for Adolescents With Early Life Adversity
Led by University of California, Irvine · Updated on 2026-05-06
300
Participants Needed
1
Research Sites
351 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Youth exposed to early life adversity (ELA) are known to be at greater risk for depression and suicidality and account for almost half of the youth suffering from psychiatric diseases today. Youth exposed to ELA consistently report symptoms of anhedonia as well as dysregulated positive affect. The present project will test the efficacy of PAT in a sample of ELA-exposed adolescents in order to determine whether PAT increases positive affect, and subsequently symptoms of depression. For the initial pilot phase of the investigation, the investigators will recruit up to 30 adolescents exposed to two or more childhood adversities (ACEs) who do not currently have major depressive disorder, and randomize them (1:1) to either participate in PAT or a waitlist control condition. For the second phase of the investigation, the investigators will recruit up to 300 adolescents exposed to two or more childhood adversities (ACEs) who do not currently have major depressive disorder, and randomize them (1:1) to either participate in PAT or supportive psychotherapy. For both phases, at study enrollment, then 4-, 8, and 12-months thereafter the investigators will measure positive affect and depressive symptoms (including anhedonia and reward sensitivity). The results of this study will be used to inform whether PAT has the potential to prevent major depressive episodes among adversity-exposed youth.
CONDITIONS
Official Title
Positive Affect Treatment for Adolescents With Early Life Adversity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 12 to 16 years
- Exposed to two or more adverse childhood experiences (ACEs)
You will not qualify if you...
- Currently taking an antidepressant or medications affecting immune function daily (e.g., steroids for asthma or allergies)
- Current or past history of manic or psychotic symptoms
- Parent-reported diagnosis of intellectual disability or autism spectrum disorder
- Chronic medical conditions such as cancer, rheumatoid arthritis, diabetes, or multiple sclerosis
- Bleeding disorders such as hemophilia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California Irvine
Irvine, California, United States, 92617
Actively Recruiting
Research Team
K
Kate R Kuhlman, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here